Displaying items 13-24 of 583
» View wsbtradio.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-49
•
Next >
-
Melanoma Survivor Who Beat Long Odds Writes Of Cancer's Gifts
The Hartford CourantIt was November, 2006, when Robert V. Heffernan felt something on the top of his head. "It was like this little bump. I thought it was a pimple. One of the mistakes I made, I kept thinking it was a pimple. Part of it is, there is some intuition in you...Tags: New Haven (New Haven, Connecticut), Science, Diseases and Illnesses, Skin Cancer, Medical Research
-
New home, same focus
South Bend TribuneSOUTH BEND -- The Northern Indiana Affiliate of the Susan G. Komen Foundation hopes the annual Race for the Cure has found a permanent home at Potawatomi Park. After years of snow, rain and sleet, the organizers think moving the event, which raises money...Tags: Services and Shopping, Event Planning, Susan G. Komen for the Cure, Planned Parenthood, Breast Cancer
-
Angelina Jolie made right choice
I was truly horrified to read the "Dear Pharmacist" column, "Why I disagree with Angelina Jolie's mastectomy decision." Suzy Cohen may be a pharmacist, but she is not a medical or surgical oncologist, nor is she a certified genetics counselor. Therefore,...Tags: Health and Medical Professionals, Mastectomy, Chemotherapy, Breast Cancer, Angelina Jolie
-
New service matches patients with clinical-research trials in Orlando
In Orlando, more than 550 clinical trials are looking for participants to help find better treatments and cures for such chronic diseases as cancer, AIDS and diabetes. Across Florida, nearly 2,500 studies are looking for subjects. "We have a lot of...
Tags: AIDS, Trials, Diseases and Illnesses, Medical Research, Testicular Cancer
-
More women removing ovaries to prevent cancer
Ovarian cancer can be a death sentence for many women. It is difficult to treat and often goes undetected until the late stages when it has spread to other organs in the pelvis and abdomen. Actress Angelina Jolie has reportedly decided to have her...
Tags: Osteoporosis, Ovarian Cancer, Hysterectomy, Medical Research, Demographics
-
Mejora supervivencia después del trasplante de células hematopoyéticas
ReutersPor Robert Saunders NUEVA YORK (Reuters Health) - Desde mediados de los años 90, la supervivencia en los primeros meses posteriores a un trasplante alogénico de células hematopoyéticas mejoró significativamente y también aumentaron las tasas de...Tags: Medical Specialization
-
Clovis shares double on positive early data for lung cancer drug
ReutersJune 3 (Reuters) - Clovis Oncology said initial results of an early-stage trial of its experimental lung cancer drug showed a reduction in tumor size, prompting investors to more than double the company's market value on Monday. The experimental therapy,...Tags: Ovarian Cancer, Diseases and Illnesses, Lung Cancer
-
Longer tamoxifen use reduces breast cancer recurrence
ReutersBy Deena Beasley CHICAGO, June 3 (Reuters) - Breast cancer is less likely to recur if women previously treated for the disease take the drug tamoxifen for 10 years, instead of the recommended five years, according to a British study. The study was a...Tags: University of Oxford, New York University, Endometrial cancer, Tamoxifen (drug), United Kingdom
-
BioMarin's cancer drug success prompts launch of pivotal trial
ReutersJune 3 (Reuters) - An experimental cancer drug from BioMarin Pharmaceutical Inc has proven to be effective in treating patients with breast or ovarian cancers caused by mutation in the BRCA gene that repairs damaged DNA, early data show. The drug,...Tags: Science and Technology, Ovarian Cancer, Biotechnology Industry, Chemical Industry, Breast Cancer
-
Bayer's Nexavar shown to delay thyroid cancer by 5 months
ReutersFRANKFURT, June 2 (Reuters) - Bayer said on Sunday its cancer drug Nexavar was shown to delay progression of a difficult-to-treat type of thyroid cancer by about five months, as the German drugmaker seeks to widen the use of the pill. The indication,...Tags: Trials, Prescription Drugs, Placebo, Drugs and Medicines, Litigation
-
Roche's Avastin fails to prolong survival in brain cancer study
ReutersBy Bill Berkrot June 2 (Reuters) - The widely used Roche Holding AG cancer drug Avastin failed to prolong survival when added to chemo-radiation therapy for glioblastoma - a fast-growing type of brain tumor - according to data presented on Sunday....Tags: High Blood Pressure, Food and Drug Administration, Medical Research, Drugs and Medicines, Chemotherapy
-
Examining which cancer screenings you may not need
Early detection of cancer is the best chance of cure, right? Maybe not. A growing body of counterintuitive evidence suggests that some cancer-screening tests — including those for breast, prostate, colon, lung and cervical cancer — may be...
Tags: Health Organizations, Medical Research, Dartmouth College, Chemotherapy, Lung Cancer
Jun 12, 2013
|Story| Hartford Courant
Jun 10, 2013
|Story| South Bend Tribune
Jun 10, 2013
|Story| South Florida Sun-Sentinel
Jun 12, 2013
|Story| Orlando Sentinel
Jun 12, 2013
|Story| Baltimore Sun
Jun 14, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 2, 2013
|Story| Reuters
Jun 2, 2013
|Story| Reuters
May 29, 2013
|Story| Orlando Sentinel
Original site for Oncology topic gallery.